Companies / Exagen Inc. / Activity
Activity — Exagen Inc.
12 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Black Jeffrey G. Executive | Grant | Common Stock | $237.0K | +75K +28.04% | 342,442 1.41% of shares | low |
| Mar 3, 2026 | Aballi John CEO | Sell | Common Stock | $56.8K | -16K -2.23% | 687,299 2.84% of shares | low |
| Feb 24, 2026 | Aballi John CEO | Sell | Common Stock | $41.3K | -11K -1.60% | 702,997 2.90% of shares | low |
| Mar 3, 2026 | Aballi John CEO | Grant | Common Stock | $7.8K | +3K +0.37% | 689,834 2.85% of shares | low |
| Feb 24, 2026 | Black Jeffrey G. Executive | Sell | Common Stock | $5.7K | -2K -0.59% | 267,442 1.10% of shares | low |
| Feb 27, 2026 | Black Jeffrey G. Executive | Grant | Common Stock | $4.6K | +2K +0.44% | 343,953 1.42% of shares | low |
| Mar 12, 2026 | Aballi John CEO | Grant | Common Stock | $0 | +150K +21.74% | 839,834 3.47% of shares | low |
| Jun 9, 2026 | Stokes Frank Director | Grant | Stock Option(right to buy) | — | +38K +50.00% | 112,500 0.46% of shares | low |
| Jun 9, 2026 | McKhann Chas Director | Grant | Stock Option(right to buy) | — | +38K +500.00% | 45,000 0.19% of shares | low |
| Jun 9, 2026 | Kahn Scott D Director | Grant | Stock Option(right to buy) | — | +38K +416.67% | 46,500 0.19% of shares | low |
| Mar 12, 2026 | Aballi John CEO | Grant | Stock Option(right to buy) | — | +100K +133.33% | 175,000 0.72% of shares | low |
| Mar 12, 2026 | Black Jeffrey G. Executive | Grant | Stock Option(right to buy) | — | +50K +500.00% | 60,000 0.25% of shares | low |